Table 1. Baseline characteristic between iCAF high patient and iCAF low patient in PDAC from Shanghai General Hospital and Minhang Hospital.
| Clinical features | iCAF-high, mean ± SD | iCAF-low, mean ± SD | P/χ2 |
|---|---|---|---|
| Age, years | 60.9±10.3 | 61.3±8.7 | P=0.875008 |
| Size, cm | 2.9±1.1 | 3.5±1.3 | P=0.071009 |
| Weight, kg | 66.4±9.1 | 63.3±10.52 | P=0.262188 |
| Gender, n | χ2=0.000514 | ||
| Male | 14 | 28 | |
| Female | 7 | 16 | |
| TNM stage, n | χ2=0.00367 | ||
| 1a | 3 | 4 | |
| 1b | 6 | 19 | |
| 2a | 3 | 8 | |
| 2b | 9 | 13 | |
| CA125, U/mL | 23.5±16.9 | 37.4±43.1 | P=0.164621 |
| CA199, U/mL | 1,108.7±4,476.2 | 233.5±477 | P=0.211595 |
iCAFs, inflammatory cancer-associated fibroblasts; PDAC, pancreatic ductal adenocarcinoma; TNM, tumor node metastasis.